BX 471 - ≥98%(HPLC), high purity , CAS No.217645-70-0, Antagonist of CCR1

Item Number
B286564
Grouped product items
SKUSizeAvailabilityPrice Qty
B286564-5mg
5mg
In stock
$79.90
B286564-10mg
10mg
In stock
$129.90
B286564-25mg
25mg
In stock
$239.90
B286564-50mg
50mg
In stock
$439.90
B286564-100mg
100mg
In stock
$639.90

Potent, selective CCR1 antagonist

Basic Description

SynonymsBX471 | BX-471 | BX-471 free base | BX 471 | (R)-1-(5-chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea | ZK-811752 | [5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea | BX-741
Specifications & PurityMoligand™, ≥98%(HPLC)
Biochemical and Physiological MechanismsEfficient selective non peptide CCR1 antagonist (KI = 1 nm of human CCR1). The selectivity for CCR1 is 250 times that of CCR2, CCR5 and CXCR4. Inhibit MIP- α/ CCL3 induced intracellular Ca2 + mobilization. Effectively reduce the disease severity of multi
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of CCR1
Product Description

Product Application
BX471 has been used in chemotaxis assay to study the responses of HEK293 cells expressing human C-C motif chemokine receptor 1 (CCR1) to CC motif ligand 3 (CCL3)-induced cell migration. It has also been used as a CCR1 inhibitor to assess the effects of CCR1 on the migration and epithelial-mesenchymal transition (EMT).

Associated Targets(Human)

CCR1 Tchem C-C chemokine receptor type 1 (9 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name [5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea
INCHI InChI=1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1
InChi Key XQYASZNUFDVMFH-CQSZACIVSA-N
Canonical SMILES CC1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F
Isomeric SMILES C[C@@H]1CN(CCN1C(=O)COC2=C(C=C(C=C2)Cl)NC(=O)N)CC3=CC=C(C=C3)F
PubChem CID 512282
Molecular Weight 434.89

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

7 results found

Lot NumberCertificate TypeDateItem
G2416212Certificate of AnalysisMay 22, 2024 B286564
G2416213Certificate of AnalysisMay 22, 2024 B286564
J2214466Certificate of AnalysisJun 21, 2022 B286564
J2214486Certificate of AnalysisJun 21, 2022 B286564
J2214505Certificate of AnalysisJun 21, 2022 B286564
J2214508Certificate of AnalysisJun 21, 2022 B286564
J2214519Certificate of AnalysisJun 21, 2022 B286564

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 43.49, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 21.74, Max Conc. mM: 50
SensitivityHygroscopic,Heat Sensitive

Safety and Hazards(GHS)

Pictogram(s) GHS09,   GHS07
Signal Warning
Hazard Statements

H302:Harmful if swallowed

H400:Very toxic to aquatic life

Precautionary Statements

P273:Avoid release to the environment.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P391:Collect spillage.

P330:Rinse mouth.

P301+P317:IF SWALLOWED: Get medical help.

Related Documents

References

1. Liang M, Mallari C, Rosser M, Ng HP, May K, Monahan S, Bauman JG, Islam I, Ghannam A, Buckman B et al..  (2000)  Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1..  J Biol Chem,  275  (25): (19000-8).  [PMID:10748002] [10.1021/op500134e]
2. Anders HJ, Vielhauer V, Frink M, Linde Y, Cohen CD, Blattner SM, Kretzler M, Strutz F, Mack M, Gröne HJ et al..  (2002)  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation..  J Clin Invest,  109  (2): (251-9).  [PMID:11805137] [10.1021/op500134e]
3. Furuichi K, Gao JL, Horuk R, Wada T, Kaneko S, Murphy PM.  (2008)  Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury..  J Immunol,  181  (12): (8670-6).  [PMID:19050287] [10.1021/op500134e]

Solution Calculators